PMV Pharmaceuticals Inc expected to post a loss of 44 cents a share - Earnings Preview

Pmv Pharmaceuticals

24/02/2023 17:20

* PMV Pharmaceuticals Inc  PMVP.OQ   PMVP.O  is expected
to show
no change in quarterly revenue when it reports  results on
February 27 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for PMV Pharmaceuticals
Inc
is for a loss of 44 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $28​, above​ its last closing price
of $7.29. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.43       -0.42      -0.40     Beat    5.5
 Jun. 30 2022  -0.42       -0.41      -0.38     Beat    6.9
 Mar. 31 2022  -0.43       -0.40      -0.41     Missed  -1.7​
 Dec. 31 2021  -0.35       -0.35      -0.40     Missed  -15.4
 ​​Sep.        -0.30       -0.30      -0.33     Missed  -9.4
 30 2021                                                
 Jun. 30 2021  -0.30       -0.28      -0.29     Missed  -2.8​
 Mar. 31 2021  -0.24       -0.24      -0.26     Missed  -8.3
 Dec. 31 2020              -0.57                        
 This summary was machine generated February 24 at 17:20 GMT. 
All figures in US dollars  unless otherwise stated